Impact of Remdesivir on Heart Rate and Bradycardia Incidence Among Hospitalized Adults With COVID-19
Remdesivir was associated with a significantly lower HR and higher incidence of bradycardia among hospitalized patients with COVID-19. These data may help improve recognition and management of these remdesivir-associated effects during COVID-19 treatment.
Authors
- Robert W. Seabury (ORCID: https://orcid.org/0000-0002-0365-6713)
- Wesley D. Kufel (ORCID: https://orcid.org/0000-0001-7703-096X)
- Nabil Zeineddine
- Stephen James Thomas (ORCID: https://orcid.org/0000-0002-8368-7682)
- Sarah A. Spinler (ORCID: https://orcid.org/0000-0003-4552-0053)
- Zoey J. Zagoria (ORCID: https://orcid.org/0009-0003-4260-1672)
- Jeffrey M. Steele (ORCID: https://orcid.org/0000-0003-3138-3609)
Institutions
- Binghamton University (US)
- Brooklyn Hospital Center (US)
- SUNY Upstate Medical University (US)
- Upstate University Hospital (US)
Publication Details
- Journal
- Annals of Pharmacotherapy
- Published
- 2025-04-23
- DOI
- https://doi.org/10.1177/10600280251327154
- Citations
- 3
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 4.19